Technical Analysis for AOXG - Aoxing Pharmaceutical Company Inc.

Grade Last Price % Change Price Change
grade C 0.024 90.48% 0.0114
AOXG closed up 90.48 percent on Wednesday, August 21, 2019, on 2.02 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical AOXG trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%

Older signals for AOXG ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. was founded in 1655 and is headquartered in Shijiazhuang, China.
RTT Pharmaceutical Drugs Pain Medication Alcohols Morphinans Opioids Opioid Acute And Chronic Pain Drug Rehabilitation Buprenorphine Buprenorphine/Naloxone Naloxone Opioid Antagonists
Is AOXG a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.069
52 Week Low 0.0001
Average Volume 5,452
200-Day Moving Average 0.0269
50-Day Moving Average 0.0166
20-Day Moving Average 0.0157
10-Day Moving Average 0.0144
Average True Range 0.0048
ADX 24.95
+DI 57.1006
-DI 24.1124
Chandelier Exit (Long, 3 ATRs ) 0.0146
Chandelier Exit (Short, 3 ATRs ) 0.0267
Upper Bollinger Band 0.0262
Lower Bollinger Band 0.0052
Percent B (%b) 0.9
BandWidth 133.757962
MACD Line -0.0002
MACD Signal Line -0.0008
MACD Histogram 0.0005
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0414
Resistance 3 (R3) 0.0395 0.0317 0.0385
Resistance 2 (R2) 0.0317 0.0273 0.0327 0.0375
Resistance 1 (R1) 0.0279 0.0246 0.0298 0.0298 0.0366
Pivot Point 0.0201 0.0201 0.0211 0.0211 0.0201
Support 1 (S1) 0.0163 0.0157 0.0182 0.0182 0.0114
Support 2 (S2) 0.0085 0.0130 0.0095 0.0105
Support 3 (S3) 0.0047 0.0085 0.0095
Support 4 (S4) 0.0066